Authors : Ravi lamani R.; Dr. S. J. Manjunath

Volume/Issue : Volume 11 - 2026, Issue 7 - July

Google Scholar : https://tinyurl.com/3hawddk7

Scribd : https://tinyurl.com/4xxbauzp

DOI : https://doi.org/10.38124/ijisrt/26jul1118

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : This paper looks at the effect of Foreign Institutional Investment on the performance of stocks of ten pharmaceutical companies in India. Quarterly data from FY 2020-21 to FY 2025-26 was collected for the companies Sun Pharmaceutical, Dr Reddy’s, Cipla, Divi’s Laboratories, Lupin, Torrent Pharmaceuticals, Zydus Lifescience, Biocon, Aurobindo and Glenmark. Foreign Institutional Investment held as an independent variable, Share price at the end of the quarter and Market Capitalisation were used to measure the performance of stocks. Descriptive statistics and trend analysis were used to study the effects of institution ownership, the increase in shareholder wealth, and the volatility in stock prices. The relationship between Foreign Institutional Investment and market performance indicators was measured using Pearson Correlation. Ordinary Least Squares Regression was used to find out the effect of one percentage point change in Foreign Institutional Investment on Share Price and Market Capitalisation for each company. The findings indicate a positive relationship for Sun Pharma, Dr Reddy’s, Cipla, Lupin, Torrent, Zydus, and Aurobindo and significant negative for Divi’s. Though Biocon and Glenmark do not show any significant relation, Zydus showed the maximum increase in Market Capitalisation and Sun Pharma showed the maximum average Market Value. In conclusion, foreign institutional participation has shown some relation with shareholder wealth for many firms but the nature of that relation varies from firm to firm within the Indian pharmaceutical market.

Keywords : Foreign Institutional Investment, Share Price, Market Capitalisation, Shareholder Wealth, Pharmaceutical Companies.

References :

1. Badhani, K. N., & Kumar, A. (2020). Market timing skill of foreign portfolio investors in India. IIMB Management Review, 32(1), 24–38. https://doi.org/10.1016/j.iimb.2019.07.012
2. Behera, C., & Rath, B. N. (2021). The COVID-19 pandemic and Indian pharmaceutical companies: An event study analysis. Bulletin of Monetary Economics and Banking, 24(Special Issue), 1–14. https://doi.org/10.21098/bemp.v24i0.1483
3. Bhaumik, S. K., Driffield, N., & Pal, S. (2010). Does ownership structure of emerging-market firms affect their outward FDI? The case of the Indian automotive and pharmaceutical sectors. Journal of International Business Studies, 41(3), 437–450. https://doi.org/10.1057/jibs.2009.52
4. Brennan, M. J., & Cao, H. H. (1997). International portfolio investment flows. The Journal of Finance, 52(5), 1851–1880. https://doi.org/10.1111/j.1540-6261.1997.tb02744.x
5. Chandra, A. (2012). Cause and effect between FII trading behaviour and stock market returns: The Indian experience. Journal of Indian Business Research, 4(4), 286–300. https://doi.org/10.1108/17554191211274794
6. Dhingra, V. S., Gandhi, S., & Bulsara, H. P. (2016). Foreign institutional investments in India: An empirical analysis of dynamic interactions with stock market return and volatility. IIMB Management Review, 28(4), 212–224. https://doi.org/10.1016/j.iimb.2016.10.001
7. Lobo, S., & Bhat, S. (2024). Unveiling investor behavior: An investigation into India’s pharmaceutical sector during COVID-19. Investment Management and Financial Innovations, 21(3), 399–411. https://doi.org/10.21511/imfi.21(3).2024.32
8. Lourdesraj, A. A., Babu, M., Gayathri, J., Indhumathi, G., & Sathya, J. (2021). Efficiency of Nifty Pharma Index during the COVID-19 pandemic in India. Academy of Strategic Management Journal, 21(S1), 1–7.
9. Mukherjee, P., & Tiwari, S. (2022). Trading behaviour of foreign institutional investors: Evidence from Indian stock markets. Asia-Pacific Financial Markets, 29(4), 605–629. https://doi.org/10.1007/s10690-022-09361-z
10. Parab, N., & Reddy, Y. V. (2020). A cause and effect relationship between FIIs, DIIs and stock market returns in India: Pre- and post-demonetization analysis. Future Business Journal, 6, Article 25. https://doi.org/10.1186/s43093-020-00029-6
11. Richards, A. (2005). Big fish in small ponds: The trading behavior and price impact of foreign investors in Asian emerging equity markets. Journal of Financial and Quantitative Analysis, 40(1), 1–27. https://doi.org/10.1017/S0022109000001721
12. Varghese, A., Santhosh, A. K., Anjana, K. M., & Francis, R. (2025). Fundamental research and analysis of India pharmaceutical sector. Shanlax International Journal of Arts, Science and Humanities, 12(S1), 124–130. https://doi.org/10.34293/sijash.v12iS1-June.9127